Clinical Trials Directory

Trials / Unknown

UnknownNCT02725034

Diagnosis of Gastric Intestinal Metaplasia With High Definition Endoscopy and Optic Enhancement

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess whether high definition endoscopy with Optic Enhancement can reduce the biopsy number needed per patient for the detection of gastric intestinal metaplasia without the loss of corresponding diagnostic yield

Detailed description

Gastric intestinal metaplasia is regarded as an important premalignant lesion for intestinal type gastric cancer. Currently, the histological assessment of gastric intestinal metaplasia still relies on the biopsies took from five sites that the updated Sydney System recommended. However, the updated Sydney System biopsy protocol needs more biopsy number and procedure time, for it is unable to satisfy the diagnosis of gastric intestinal metaplasia. Optic Enhancement is a novel image-enhanced endoscopy system. Targeted biopsy protocol based on high definition endoscopy with Optic Enhancement will be possible for the diagnosis of gastric intestinal metaplasia. This study aims to compare the diagnostic yield of gastric intestinal metaplasia from high definition endoscopy with Optic Enhancement targeted biopsies and a standard biopsy protocol and assess whether high definition endoscopy with Optic Enhancement can reduce the biopsy number needed per patient for the detection of gastric intestinal metaplasia without the loss of corresponding diagnostic yield.

Conditions

Interventions

TypeNameDescription
DEVICEStandard endoscopy
DEVICEHigh definition endoscopy with Optic Enhancement

Timeline

Start date
2016-01-01
Primary completion
2016-08-01
First posted
2016-03-31
Last updated
2016-03-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02725034. Inclusion in this directory is not an endorsement.